Search research articles
Contact Us
Filters
Showing results (71-80 of 133) with videos related to
Page
of 14
Sort By:
Bone Marrow Transplantation
|
October 6, 2010
Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT
L Castagna, S Fürst, N Marchetti, et al.
La Revue De Medecine Interne
|
January 29, 2019
[CAR-T cells: Lymphocytes that express a chimeric antigen receptor]
C Chabannon, R Bouabdallah, S Fürst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis
R Bouabdallah, N Mounier, C Guettier, et al.
Blood
|
June 14, 2000
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA)
N Mounier, C Haioun, B F Cole, et al.
Bone Marrow Transplantation
|
March 3, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
S Garciaz, L Castagna, R Bouabdallah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma
F Morschhauser, S Depil, E Jourdan, et al.
Leukemia Research
|
February 13, 2001
Primary plasma cell leukaemia: a report of 18 cases
R Costello, D Sainty, R Bouabdallah, et al.
Bone Marrow Transplantation
|
June 4, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
S Garciaz, L Castagna, R Bouabdallah, et al.
Bone Marrow Transplantation
|
November 3, 2015
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity
S Garciaz, D Coso, J-M Schiano de Collela, et al.
The New England Journal of Medicine
|
July 24, 1997
Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group
F Guilhot, C Chastang, M Michallet, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 133) with videos related to
Sort By:
Page
of 14
Bone Marrow Transplantation
|
October 6, 2010
Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT
L Castagna, S Fürst, N Marchetti, et al.
La Revue De Medecine Interne
|
January 29, 2019
[CAR-T cells: Lymphocytes that express a chimeric antigen receptor]
C Chabannon, R Bouabdallah, S Fürst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis
R Bouabdallah, N Mounier, C Guettier, et al.
Blood
|
June 14, 2000
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA)
N Mounier, C Haioun, B F Cole, et al.
Bone Marrow Transplantation
|
March 3, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
S Garciaz, L Castagna, R Bouabdallah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma
F Morschhauser, S Depil, E Jourdan, et al.
Leukemia Research
|
February 13, 2001
Primary plasma cell leukaemia: a report of 18 cases
R Costello, D Sainty, R Bouabdallah, et al.
Bone Marrow Transplantation
|
June 4, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
S Garciaz, L Castagna, R Bouabdallah, et al.
Bone Marrow Transplantation
|
November 3, 2015
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity
S Garciaz, D Coso, J-M Schiano de Collela, et al.
The New England Journal of Medicine
|
July 24, 1997
Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group
F Guilhot, C Chastang, M Michallet, et al.
Page
of 14